Table 1.
Age and sex-adjusted characteristics (95% confidence intervals for the mean) according to cumulative socioeconomic position (SEP) score
| Cumulative SEP score |
|||
|---|---|---|---|
| 0-1 (n=343) |
2-3 (n= 553) |
4-6 (n=617) |
|
|
Clinical Characteristics
| |||
| Age, years | 63.7(62.8,64.6) | 58.8(58.1,59.4) | 57.9(57.3,58.6) |
| Female, % | 56.6(51.1,61.9) | 59.9(55.6,64.0) | 46.0(42.0,50.1) |
| Current Smoker, % | 20.1(16.1,24.9) | 14.0(11.4,17.1) | 8.4(6.5,10.8) |
| Body Mass Index, kg/m2 | 29.0(28.4,29.5) | 28.5(28.1,28.9) | 27.7(27.3,28.1) |
| Systolic Blood Pressure, mmHg | 128(126,129) | 125(124,126) | 125(124,126) |
| Total:HDL* Cholesterol Ratio | 4.1(4.0,4.3) | 4.2(4.1,4.3) | 4.0(3.9,4.1) |
| Fasting Glucose, mg/dL | 105(102,108) | 104(102,106) | 102(100,104) |
| Taking Cholesterol-Lowering Medication, % | 23.9(19.7,28.6) | 16.4(13.5,19.7) | 15.7(131,18.8) |
| Taking Anti-Hypertensive Medication, % | 32.8(28.0,38.0) | 31.3(27.6,35.4) | 27.1(23.7,30.9) |
| Depressive Symptoms, CES-D* Score | 5.7(5.1,6.4) | 5.8(5.3,6.3) | 4.6(4.1,5.1) |
| Prevalent Cardiovascular Disease, % | 5.0(3.2,7.6) | 3.5(2.3,5.3) | 2.3(1.5,3.7) |
|
| |||
|
Inflammatory Markers
| |||
| CRP, mg/L* | 2.57(2.29,2.88) | 2.26(2.06,2.47) | 1.90(1.74,2.07) |
| IL-6, pg/mL* | 3.10(2.89,2.33) | 2.88(2.72,3.04) | 2.69(2.55,2.83) |
| ICAM-1, ng/mL* | 252(246,259) | 249(244,253) | 236(233,240) |
| TNFR2, pg/mL* | 2074(2013,2136) | 2064(2016,2112) | 1937(1894,1980) |
| Lp-PLA2 activity, nmol/min/mL* | 140(137,143) | 140(138,143) | 136(133,138) |
| P-Selectin, ng/mL* | 34.7(33.4,36.0) | 36.5(35.4,37.6) | 34.8(33.8,35.8) |
| MCP-1, pg/mL* | 316(305,327) | 304(296,313) | 299(291,307) |
| Fibrinogen, g/L* | 382(374,389) | 371(365,376) | 367(362,372) |
*
Mean inflammatory concentrations were obtained using linear regression on log-transformed variables, and then back-transformed to obtain estimates of the mean concentrations.